This is a revised application to renewal a grant focused on understanding the genetic basis of cholestasis, i.e. impairment in bile formation and/or bile flow. The current award was used to isolate a gene which, when mutated is responsible for two forms of inherited cholestasis, benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis, type 1 (PFIC1). The main goal of the renewal will be to characterize the function of this gene (termed FIC1) by a variety of in vitro and in vivo experiments. A first step will be to identify specific FIC1 mutations responsible for disease in a series of BRIC and PFIC1 patients for whom DNA samples have been collected but in whom mutations have not yet been identified; this mutation analysis will show whether particular FIC1 genotypes are correlated with specific clinical features of BRIC and PFIC1. Screening for FIC1 mutations will also be undertaken in patients with apparently sporadic forms of cholestasis. Mice will be generated in whom the murine ortholog of FIC1 (Fic1) has been disrupted. These mice will be used for anatomic, physiologic, and pharmacological studies aimed at understanding the normal function of FIC1 and as a model for studying cholestasis. These studies will complement efforts by collaborators who will use other approaches to identify the function of FIC1. It was shown recently that mutations in genes other than FIC1 cause forms of cholestasis that are distinct cl8inically, histopathologically, and biochemically from BRIC and PFIC1. Characterizing the function of these genes in conjunction with that of FIC1 will illuminate the molecular basis of normal bile formation and bile flow.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK050697-07S1
Application #
6999681
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Doo, Edward
Project Start
1996-02-01
Project End
2005-04-30
Budget Start
2004-09-01
Budget End
2005-04-30
Support Year
7
Fiscal Year
2005
Total Cost
$63,919
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Shah, Sohela; Sanford, Ukina R; Vargas, Julie C et al. (2010) Strain background modifies phenotypes in the ATP8B1-deficient mouse. PLoS One 5:e8984
Pawlikowska, Ludmila; Strautnieks, Sandra; Jankowska, Irena et al. (2010) Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 53:170-8
Strautnieks, Sandra S; Byrne, Jane A; Pawlikowska, Ludmila et al. (2008) Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134:1203-14
Knisely, A S; Strautnieks, Sandra S; Meier, Yvonne et al. (2006) Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44:478-86
Paulusma, Coen C; Groen, Annemiek; Kunne, Cindy et al. (2006) Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 44:195-204
Klomp, Leo W J; Vargas, Julie C; van Mil, Saskia W C et al. (2004) Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 40:27-38
van Mil, Saskia W C; van der Woerd, Wendy L; van der Brugge, Gerda et al. (2004) Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127:379-84
Carlton, Victoria E H; Pawlikowska, Ludmila; Bull, Laura N (2004) Molecular basis of intrahepatic cholestasis. Ann Med 36:606-17
Pawlikowska, Ludmila; Groen, Annemiek; Eppens, Elaine F et al. (2004) A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet 13:881-92
Bull, Laura N (2002) Hereditary forms of intrahepatic cholestasis. Curr Opin Genet Dev 12:336-42

Showing the most recent 10 out of 16 publications